AKT1 and prostate cancer: pTen is known to downregulate IGF-II and IGF-IR expression in hepatoma and prostate cancer cells [48], [49], suggesting that the expression of a constitutively-active AKT in Ishikawa cells may induce an increase in IGF-IR expression.